The results of research studies conducted GDUFA initiatives provide new tools for FDA to evaluate generic drug equivalence.
Similar Posts
Zhejiang Huahai Pharmaceutical Co., Ltd. – 707145 – 06/06/2025
CGMP/Finished Pharmaceuticals/AdulteratedConcord Biotech Limited – 04/28/2025-05/02/2025
Concord Biotech Limited – 04/28/2025-05/02/2025. Country: India. Record Type: 483Medical Gases — Current Good Manufacturing Practice
Pharmaceutical Quality/Manufacturing Standards (CGMP)Timeline of Selected FDA Activities and Significant Events Addressing Substance Use and Overdose Prevention
Timeline of Selected FDA Activities and Significant Events Addressing Opioid Misuse and AbuseFDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
The U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and olderCorrection Alert: Olympus Updates Use Instructions for Ligating Device
Olympus ligation loops may be unable to release or detach as expected during use and may become unintentionally anchored around patient anatomy